SC 13D

Company

Forte Biosciences, Inc.

Filed

August 1, 2022

Accession Number

0001140361-22-027620

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →